Virtue-Based vs. Cognitive-Behavioral Interventions in Patients With Chronic Medical Disease
Launched by UNIVERSITY OF VALENCIA · Jul 8, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of therapy to help improve well-being in individuals who have chronic medical conditions, such as diabetes or cancer. The first type of therapy is called Cognitive Behavioral Therapy (CBT), which helps people recognize and change negative thoughts and behaviors. The second is called Virtue-Based Intervention (VBI), which focuses on building personal strengths and resources. The trial will compare these two therapies to see how they work and how they can help participants feel better over time. Participants will take part in the study for several months and will be evaluated at different points to track their progress.
To join the study, individuals must be between 18 and 70 years old, able to read and write in Spanish, and have access to a computer and the internet. They should also have a low level of well-being and a diagnosed chronic medical condition. However, those with certain mental disorders or severe complications from their medical condition that need hospital treatment cannot participate. This trial is currently recruiting participants, and it offers a chance to try new therapies that could enhance well-being and improve quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged between 18 and 70 years old.
- • 2. Able to read and write in Spanish.
- • 3. Having a computer with internet access in a safe place (home or private office) and the skills to use it.
- • 4. Having a low level of well-being (i.e., a score of less than 13 on the WHO well-being index, assessed with the WHO-5 questionnaire).
- • 5. Having a diagnosis of a chronic medical disease (diabetes, epilepsy, cancer, etc.) according to standard criteria.
- Exclusion Criteria:
- • 1. Diagnosis of a mental disorder assessed with the Spanish edition of the Mini-International Neuropsychiatric Interview (MINI).
- • 2. Complications of the chronic medical disease that require hospital treatment.
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Trial Officials
Ausiàs Cebolla Martí, PhD
Principal Investigator
Univeristy of Valencia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported